VAN ECK ASSOCIATES CORP - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 129 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q3 2023$23
+228.6%
1,334
+142.5%
0.00%
Q2 2023$70.0%5500.0%0.00%
Q1 2023$7
-12.5%
550
-1.8%
0.00%
Q4 2022$8
-99.7%
560
+67.7%
0.00%
Q3 2022$3,000
+50.0%
334
+88.7%
0.00%
Q2 2022$2,0000.0%177
+118.5%
0.00%
Q1 2022$2,000
-33.3%
810.0%0.00%
Q4 2021$3,0000.0%810.0%0.00%
Q3 2021$3,000
+200.0%
81
+131.4%
0.00%
Q2 2021$1,000350.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 2,339,885$93,421,00021.31%
UG Investment Advisers Ltd. 33,155$1,302,0002.52%
Pinz Capital Management, LP 159,400$6,260,0001.88%
Capital International Sarl 547,743$21,510,0001.86%
Capital International, Inc./CA/ 4,391,684$172,461,0001.54%
AIA Group Ltd 437,118$17,380,0001.20%
York Capital Management Global Advisors, LLC 182,297$7,159,0000.80%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 68,000$2,671,0000.70%
E Fund Management (Hong Kong) Co., Ltd. 18,579$730,0000.46%
M&G INVESTMENT MANAGEMENT LTD 4,512,562$175,990,0000.44%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders